FDA Peptide Reclassification 2026: What Researchers Want FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies Save Peptides Save Peptides : ? The FDA just removed 12 peptides (BPC157, TB500, Epitalon, GHKCu inj., DSIP, MOTSc, Semax, PEGMGF, Melanotan II, LL37, Dihexa, KPV) from Category 2 (donotcompound Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them